£1.2M trial to test effectiveness of cognitive behavior...( A team of researchers led by Dr Nico...),Health
A team of researchers, led by Dr Nicola Wiles at the University of Bristol and involving researchers from the Peninsula Medical School in the South West, has been awarded 1.2 million by the National Institute for Health Research Health Technology Assessment (NIHR HTA) programme for a clinical trial to investigate the effectiveness of cognitive behavioural therapy (CBT) for patients with depression who do not respond to treatment with antidepressants.
Patients who have been taking antidepressants for at least six weeks will be invited to participate in the trial and receive either CBT in addition to their medication, or continue with usual care from their general practitioner (including medication). Both groups will be followed up for 12 months to see which approach is the most effective in reducing depressive symptoms and improving quality of life. Recruitment for the trial is due to start in the autumn.
The Bristol team, in partnership with researchers from the University of Exeter, the Peninsula Medical School, the University of Glasgow and the Avon and Wiltshire Mental Health Partnership, will also evaluate the cost-effectiveness of the treatment and patients' views and experiences of it.
Dr Nicola Wiles said: "CBT has been shown to help patients with depression but there is currently little evidence about what alternative treatment options doctors should discuss with patients who do not get better with antidepressants. Improving access to psychological therapies is a Government priority, so it is important that we conduct studies such as this to help inform the care of people with depression."
Professor Campbell (Peninsula Medical School) said: "This study offers the opportunity for patients in the South West to contribute to an important piece of research which will help define the best mode of treatment for patients suffering from depression. The study will bring together a team of researchers from Peninsula Medical S
'/>"/>
| Contact: Andrew Gould media@pr-works.co.uk 44-139-268-6107 The Peninsula College of Medicine and Dentistry Source:Eurekalert |
Related medicine news :
1. New Heart Pump Shows Promise in Trial
2. Trial to Test Gene Therapy for Angina in Women
3. AKELA Pharma Inc. announces positive results for the extension part of its Phase IIb Fentanyl TAIFUN(R) trial
4. The New England Journal of Medicine Publishes EURIDIS/ADONIS Study Results Showing Dronedarone Maintained Sinus Rhythm in Patients With Atrial Fibrillation or Flutter With no Observed Pro-Arrhythmia
5. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
6. MDS Pharma Services Wins Award for Management of Global Malaria Trial
7. New Ovarian Cancer Drug Trial Under Way
8. Study Questions Dead-End Cancer Clinical Trials
9. AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System
10. CryoCor Invited to Participate in FDA Advisory Panel Meeting on Atrial Fibrillation
11. Clinical trials present better alternatives for dialysis patients
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |